JP2016536357A5 - - Google Patents

Download PDF

Info

Publication number
JP2016536357A5
JP2016536357A5 JP2016550931A JP2016550931A JP2016536357A5 JP 2016536357 A5 JP2016536357 A5 JP 2016536357A5 JP 2016550931 A JP2016550931 A JP 2016550931A JP 2016550931 A JP2016550931 A JP 2016550931A JP 2016536357 A5 JP2016536357 A5 JP 2016536357A5
Authority
JP
Japan
Prior art keywords
use according
pancreatitis
dimer
domain
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016550931A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016536357A (ja
JP6825181B2 (ja
Filing date
Publication date
Priority claimed from CN201310549648.XA external-priority patent/CN104623639A/zh
Application filed filed Critical
Publication of JP2016536357A publication Critical patent/JP2016536357A/ja
Publication of JP2016536357A5 publication Critical patent/JP2016536357A5/ja
Application granted granted Critical
Publication of JP6825181B2 publication Critical patent/JP6825181B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016550931A 2013-11-07 2014-11-06 膵炎を治療するための薬剤の製造におけるil−22二量体の使用 Active JP6825181B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201310549648.XA CN104623639A (zh) 2013-11-07 2013-11-07 白介素22二聚体在制备治疗胰腺炎药物中的应用
CN201310549648.X 2013-11-07
PCT/CN2014/090519 WO2015067198A1 (en) 2013-11-07 2014-11-06 Use of il-22 dimers in manufacture of medicaments for treating pancreatitis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019129934A Division JP2019206548A (ja) 2013-11-07 2019-07-12 膵炎を治療するための薬剤の製造におけるil−22二量体の使用

Publications (3)

Publication Number Publication Date
JP2016536357A JP2016536357A (ja) 2016-11-24
JP2016536357A5 true JP2016536357A5 (enExample) 2017-12-14
JP6825181B2 JP6825181B2 (ja) 2021-02-03

Family

ID=53040916

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016550931A Active JP6825181B2 (ja) 2013-11-07 2014-11-06 膵炎を治療するための薬剤の製造におけるil−22二量体の使用
JP2019129934A Pending JP2019206548A (ja) 2013-11-07 2019-07-12 膵炎を治療するための薬剤の製造におけるil−22二量体の使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019129934A Pending JP2019206548A (ja) 2013-11-07 2019-07-12 膵炎を治療するための薬剤の製造におけるil−22二量体の使用

Country Status (8)

Country Link
US (1) US20160271221A1 (enExample)
EP (1) EP3065765B1 (enExample)
JP (2) JP6825181B2 (enExample)
CN (2) CN104623639A (enExample)
AU (1) AU2014346051B2 (enExample)
CA (1) CA2929637C (enExample)
ES (1) ES2794082T3 (enExample)
WO (1) WO2015067198A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101361968B (zh) 2007-08-06 2011-08-03 健能隆医药技术(上海)有限公司 白介素-22在治疗脂肪肝中的应用
CN104623637A (zh) 2013-11-07 2015-05-20 健能隆医药技术(上海)有限公司 Il-22二聚体在制备静脉注射药物中的应用
CN106146668A (zh) * 2015-04-01 2016-11-23 中国人民解放军第二军医大学 长效白细胞介素22的制备方法及其用途
ES3043007T3 (en) * 2015-06-08 2025-11-24 Univ New York Stabilized minimal coiled-coil mimetics
CR20180087A (es) * 2015-07-16 2018-05-14 Philogen Spa Inmunoconjugados de il22
ES2930351T3 (es) 2016-04-15 2022-12-09 Evive Biotechnology Shanghai Ltd Un dímero de IL-22 para su uso en el tratamiento de enterocolitis necrosante
EP3849605A4 (en) 2018-09-10 2022-06-15 Cold Spring Harbor Laboratory METHODS OF TREATMENT OF PANCREATITIS
CN110302363B (zh) * 2019-07-04 2020-10-09 北京大学第三医院(北京大学第三临床医学院) Il-22作为制备治疗pcos药物的应用及药物制剂
WO2021164744A1 (en) 2020-02-19 2021-08-26 Evive Biotechnology (Shanghai) Ltd Methods for treating graft versus host disease

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0674506T3 (da) 1992-12-02 2001-01-08 Alkermes Inc Væksthormonholdige mikrosfærer med styret frigivelse
DE69519382T3 (de) 1994-09-09 2008-09-18 Takeda Pharmaceutical Co. Ltd. Zubereitung mit verzögerter freigabe eines metallsalz eines peptids
WO1996040072A2 (en) 1995-06-07 1996-12-19 Alkermes Controlled Therapeutics, Inc. Composition for sustained release of human growth hormone
ZA965368B (en) 1995-07-14 1997-01-14 Novo Nordisk As A pharmaceutical formulation
US6274710B1 (en) 1998-10-26 2001-08-14 Ludwig Institute For Cancer Research Antibodies which specifically bind T Cell inducible factors (TIFs)
US7597876B2 (en) * 2007-01-11 2009-10-06 Immunomedics, Inc. Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
CN100515491C (zh) 2005-01-04 2009-07-22 健能隆医药技术(上海)有限公司 白介素-22的医药用途
CN102380091A (zh) * 2010-08-31 2012-03-21 健能隆医药技术(上海)有限公司 白介素-22在治疗病毒性肝炎中的应用
US8690554B2 (en) * 2011-07-15 2014-04-08 Xylem Ip Holdings Llc Diaphragm pump using duckbill and other types of valves
PE20151673A1 (es) 2013-03-15 2015-11-27 Genentech Inc POLIPEPTIDOS DE IL-22 Y PROTEINAS DE FUSION DE IL-22 Fc Y METODOS DE USO

Similar Documents

Publication Publication Date Title
JP2017528419A5 (enExample)
RU2017134456A (ru) Рекомбинантные связывающие белки и их применение
RU2014150224A (ru) Сконструированный белок с анкириновым повтором, связывающийся с фактором роста тромбоцитов
TW201613958A (en) MIC-1 fusion proteins and uses thereof
JP2015522576A5 (enExample)
EA201290722A1 (ru) Рекомбинантный белок эксендина-4 и его аналога, способ их приготовления и применение
EA201201047A1 (ru) Способы и композиции, в которых применяют слитые полипептиды fgf 23
AR102595A1 (es) Anticuerpos anti-ang2 y métodos de utilización
WO2013080147A3 (en) Anticancer fusion protein
JP2017531613A5 (enExample)
WO2016057529A3 (en) Biphasic single-chain insulin analogues
JP2014526881A5 (enExample)
JP2018538356A5 (enExample)
JP2020507623A5 (enExample)
JP2015532307A5 (enExample)
PL393578A1 (pl) Przeciwnowotworowe białko fuzyjne
CN106232616A (zh) 两亲性合成抗菌肽、其药物组合物及其用途
FI3065763T4 (fi) Il-22-dimeerin käyttö lääkkeen valmistamisessa suonensisäistä antoa varten
JP2015504052A5 (enExample)
MX2021012047A (es) Polipeptidos de fusion de serpina y metodos para utilizar los mismos.
WO2013098755A3 (en) Anticancer fusion protein
WO2016115511A3 (en) Vegf variant polypeptide compositions
CN110799522A (zh) 用于治疗、改善或预防脑出血的肽及其用途
EA201790341A1 (ru) Анти-ск8 антитела для применения в лечении рака
JP2016515123A5 (enExample)